Cargando…

Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus

AIM: The EPICHRONIC (EPIdemiology of CHRONIC diseases) project investigated the possibility of developing common procedures for French and Spanish electronic health care databases to enable large-scale pharmacoepidemiological studies on chronic diseases. A feasibility study assessed the prevalence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Moulis, Guillaume, Ibañez, Berta, Palmaro, Aurore, Aizpuru, Felipe, Millan, Eduardo, Lapeyre-Mestre, Maryse, Sailler, Laurent, Cambra, Koldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067780/
https://www.ncbi.nlm.nih.gov/pubmed/30100760
http://dx.doi.org/10.2147/CLEP.S151890
_version_ 1783343170587721728
author Moulis, Guillaume
Ibañez, Berta
Palmaro, Aurore
Aizpuru, Felipe
Millan, Eduardo
Lapeyre-Mestre, Maryse
Sailler, Laurent
Cambra, Koldo
author_facet Moulis, Guillaume
Ibañez, Berta
Palmaro, Aurore
Aizpuru, Felipe
Millan, Eduardo
Lapeyre-Mestre, Maryse
Sailler, Laurent
Cambra, Koldo
author_sort Moulis, Guillaume
collection PubMed
description AIM: The EPICHRONIC (EPIdemiology of CHRONIC diseases) project investigated the possibility of developing common procedures for French and Spanish electronic health care databases to enable large-scale pharmacoepidemiological studies on chronic diseases. A feasibility study assessed the prevalence of type 2 diabetes mellitus (T2DM) in Navarre and the Basque Country (Spain) and the Midi-Pyrénées region (France). PATIENTS AND METHODS: We described and compared database structures and the availability of hospital, outpatient, and drug-dispensing data from 5.9 million inhabitants. Due to differences in database structures and recorded data, we could not develop a common procedure to estimate T2DM prevalence, but identified an algorithm specific to each database. Patients were identified using primary care diagnosis codes previously validated in Spanish databases and a combination of primary care diagnosis codes, hospital diagnosis codes, and data on exposure to oral antidiabetic drugs from the French database. RESULTS: Spanish and French databases (the latter termed Système National d’Information Inter-Régimes de l’Assurance Maladie [SNIIRAM]) included demographic, primary care diagnoses, hospital diagnoses, and outpatient drug-dispensing data. Diagnoses were encoded using the International Classification of Primary Care (version 2) and the International Classification of Diseases, version 9 and version 10 (ICD-9 and ICD-10) in the Spanish databases, whereas the SNIIRAM contained ICD-10 codes. All data were anonymized before transferring to researchers. T2DM prevalence in the population over 20 years was estimated to be 6.6–7.0% in the Spanish regions and 6.3% in the Midi-Pyrénées region with ~2% higher estimates for males in the three regions. CONCLUSION: Tailored procedures can be designed to estimate the prevalence of T2DM in population-based studies from Spanish and French electronic health care records.
format Online
Article
Text
id pubmed-6067780
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-60677802018-08-10 Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus Moulis, Guillaume Ibañez, Berta Palmaro, Aurore Aizpuru, Felipe Millan, Eduardo Lapeyre-Mestre, Maryse Sailler, Laurent Cambra, Koldo Clin Epidemiol Original Research AIM: The EPICHRONIC (EPIdemiology of CHRONIC diseases) project investigated the possibility of developing common procedures for French and Spanish electronic health care databases to enable large-scale pharmacoepidemiological studies on chronic diseases. A feasibility study assessed the prevalence of type 2 diabetes mellitus (T2DM) in Navarre and the Basque Country (Spain) and the Midi-Pyrénées region (France). PATIENTS AND METHODS: We described and compared database structures and the availability of hospital, outpatient, and drug-dispensing data from 5.9 million inhabitants. Due to differences in database structures and recorded data, we could not develop a common procedure to estimate T2DM prevalence, but identified an algorithm specific to each database. Patients were identified using primary care diagnosis codes previously validated in Spanish databases and a combination of primary care diagnosis codes, hospital diagnosis codes, and data on exposure to oral antidiabetic drugs from the French database. RESULTS: Spanish and French databases (the latter termed Système National d’Information Inter-Régimes de l’Assurance Maladie [SNIIRAM]) included demographic, primary care diagnoses, hospital diagnoses, and outpatient drug-dispensing data. Diagnoses were encoded using the International Classification of Primary Care (version 2) and the International Classification of Diseases, version 9 and version 10 (ICD-9 and ICD-10) in the Spanish databases, whereas the SNIIRAM contained ICD-10 codes. All data were anonymized before transferring to researchers. T2DM prevalence in the population over 20 years was estimated to be 6.6–7.0% in the Spanish regions and 6.3% in the Midi-Pyrénées region with ~2% higher estimates for males in the three regions. CONCLUSION: Tailored procedures can be designed to estimate the prevalence of T2DM in population-based studies from Spanish and French electronic health care records. Dove Medical Press 2018-07-27 /pmc/articles/PMC6067780/ /pubmed/30100760 http://dx.doi.org/10.2147/CLEP.S151890 Text en © 2018 Moulis et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Moulis, Guillaume
Ibañez, Berta
Palmaro, Aurore
Aizpuru, Felipe
Millan, Eduardo
Lapeyre-Mestre, Maryse
Sailler, Laurent
Cambra, Koldo
Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus
title Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus
title_full Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus
title_fullStr Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus
title_full_unstemmed Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus
title_short Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus
title_sort cross-national health care database utilization between spain and france: results from the epichronic study assessing the prevalence of type 2 diabetes mellitus
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067780/
https://www.ncbi.nlm.nih.gov/pubmed/30100760
http://dx.doi.org/10.2147/CLEP.S151890
work_keys_str_mv AT moulisguillaume crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus
AT ibanezberta crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus
AT palmaroaurore crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus
AT aizpurufelipe crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus
AT millaneduardo crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus
AT lapeyremestremaryse crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus
AT saillerlaurent crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus
AT cambrakoldo crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus